Sainz Maria — SEC Form 4 filings

SEC reporting owner CIK 1437768. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-28 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PULSE BIOSCIENCES, INC. (PLSE)Director24
Hyperfine, Inc. (HYPR)President and CEO, Director22
Shockwave Medical, Inc. (SWAV)Director11

Form 4 filings — Sainz Maria

FiledFormIssuerReported transactionsSource
2026-06-154PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 3,793 (derivative) @ $0EDGAR
2026-04-014Hyperfine, Inc. (HYPR)Grant/award (A): 750,000 @ $0EDGAR
2026-02-064PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 3,104 (derivative) @ $0EDGAR
2024-05-314Shockwave Medical, Inc. (SWAV)Disposition to issuer (D): 5,328EDGAR
2024-03-284Hyperfine, Inc. (HYPR)Grant/award (A): 1,435,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1437768 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →